The finding of recovered CRABP2 expression in resveratrol-treated anaplastic thyroid cancer cells has encouraged us to investigate the possible demethylating capacity of this polyphenol agent. Here, CRABP2 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.